Late Breaking Abstract - Effect of N-acetyl cysteine in a patient cohort with severe or very severe COVID-19 pneumonia
C. Gotera Rivera (Madrid, Spain), C. López Chang (Madrid, Spain), L. De La Dueña (Madrid, Spain), L. Llanos Jiménez (Madrid, Spain), R. Cortés (Madrid, Spain), O. Sánchez Pernaute (Madrid, Spain), C. Pérez Calvo (Madrid, Spain), A. Ioan (Madrid, Spain), J. Pérez (Madrid, Spain), A. Santos Oviedo (Madrid, Spain), S. Heili Frades (Madrid, Spain), A. Naya Prieto (Madrid, Spain), I. Fernández Ormaechea (Madrid, Spain), M. Carballosa De Miguel (Madrid, Spain), M. Rodríguez Nieto (Madrid, Spain), G. Peces Barba (Madrid, Spain)
Source: International Congress 2022 – COVID-19 acute respiratory distress syndrome and beyond
  
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Gotera Rivera (Madrid, Spain), C. López Chang (Madrid, Spain), L. De La Dueña (Madrid, Spain), L. Llanos Jiménez (Madrid, Spain), R. Cortés (Madrid, Spain), O. Sánchez Pernaute (Madrid, Spain), C. Pérez Calvo (Madrid, Spain), A. Ioan (Madrid, Spain), J. Pérez (Madrid, Spain), A. Santos Oviedo (Madrid, Spain), S. Heili Frades (Madrid, Spain), A. Naya Prieto (Madrid, Spain), I. Fernández Ormaechea (Madrid, Spain), M. Carballosa De Miguel (Madrid, Spain), M. Rodríguez Nieto (Madrid, Spain), G. Peces Barba (Madrid, Spain). Late Breaking Abstract - Effect of N-acetyl cysteine in a patient cohort with severe or very severe COVID-19 pneumonia. 2319
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|